尽管国内的生物技术在近年来有了较大规模的发展,不过从其技术能力以及管理问题上来看,还是存在不少弊端,经常会在项目开展中出现延误工期、安全问题频发等问题,同时投入成本还只增不减,始终保持在较高水平,实际资金往往会超出预算。生物技术项目一旦展开,其规模通常都相对较大,花费的时间和成本也比较多,再加上技术和管理能力有限,所以,其项目开展也伴随着非常大的风险。所以说,一定要加强对项目施工财务的管理,这不仅能确保施工单位的正常工作财务,而且也能提高自身竞争优势。 Although domestic biotechnology has enjoyed large-scale development in recent years, there are still many shortcomings in terms of its technical capabilities and management issues. Frequent problems such as delayed construction periods and frequent safety problems occur during the project’s development. At the same time, the cost of investment has only increased and decreased, always maintaining a relatively high level, and the actual funds tend to exceed the budget. Once developed, biotech projects are often relatively large-scale, time-consuming and costly, coupled with limited technical and managerial capacity, so there is also a great risk associated with developing projects. Therefore, we must strengthen the financial management of project construction, which not only ensures the normal work of the construction unit financial, but also improve their competitive advantage.